The Medicines Company Surges Amid Credit Suisse Upgrade
November 20, 2014 at 10:16 AM EST
Credit Suisse upgraded The Medicines Company (NASDAQ: MDCO) Thursday from Neutral to Outperform and raised its price target from $27 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|